Suppliers

Clinical Ink

Clinical Ink

Clinical Ink is a global clinical trial technology company that is transforming the clinical trial experience. By connecting clients to a proven and future-built eSource platform that accelerates time to value while delivering scientific results that matter, we’re proud to be advancing the business model responsible for bringing new treatments to market.

Latest content from Clinical Ink

Accelerating Database Lock: Adaptive Design & Remote Monitoring

Paid for and content provided by Clinical Ink

Accelerating Database Lock: Adaptive Design & Remote Monitoring

CASE STUDY: A pharmaceutical company conducting a Phase III study of an investigational ointment required an eSource solution that could support remote monitoring, video uploads, and image capture and provide push-button randomization.

Related resources

Introduction to eLAS®

Introduction to eLAS®

Content provided by Clinical Ink | 08-Mar-2021 | Product Brochure

Clinical Ink has developed a unique offering — the electronic Lupus Assessment Suite (eLAS®) to address fundamental challenges impacting systemic lupus...

A Winning End-to-End Solution for Oncology Studies

A Winning End-to-End Solution for Oncology Studies

Content provided by Clinical Ink | 22-Feb-2021 | White Paper

Oncology clinical trials present a unique set of challenges for patients, study sites, and study sponsors. Using electronic patient reported outcomes (ePRO)...